About: Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak
Creator	Malobabic, Marina Milosevic, Vuk Stanojevic, Goran Stevic, Milos Stojanov, Aleksandar Stojanov, Jelena Vojinovic, Slobodan
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: The coronavirus disease 2019 (COVID-19) is a global health emergency. The aim was to investigate the impact of COVID-19 pandemic on the psychological status of patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Data on the socio-demographic and clinical characteristics of 95 RRMS patients were collected. We used a self-designed questionnaire, the Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54), Hamilton scales for the assessment of anxiety (HAM-A), and depression (HAM-D). Patients who were tested one year ago were reassessed using the same questionnaires during the COVID-19 outbreak. Group of 99 healthy individuals (HC) were tested, using the same questionnaires. RESULTS: The main concerns in RRMS patients were that someone that they know could be infected with COVID-19 (78.5%), or could die due to the infection (33.8%), and the lack of specific treatment options (25.8%). The main concerns about the RRMS status were that their disease would be worse if they get infected with COVID-19 (36.4%), that they would experience some difficulties in drug availability (43.6%), that they could not go to the hospital as usual (72.4%). Results on all questionnaires were worse in RRMS patients than in HC (p<0.01). We noticed a statistically significant difference between the results obtained a year ago and the results from April 2020 in HAM-A (p<0.05). CONCLUSIONS: There is an impact of the COVID-19 pandemic on the psychological status of RRMS patients. Healthcare organizations need to provide professional therapeutic advice and psychosocial support for this population of patients during the pandemic.
has issue date	2020-07-16(xsd:dateTime)
bibo:doi	10.1016/j.msard.2020.102407
bibo:pmid	32702641
has license	no-cc
sha1sum (hex)	6f953f0b9f727b9ffb51103bbd8b41a7882b7061
schema:url	https://doi.org/10.1016/j.msard.2020.102407
resource representing a document's title	Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak
has PubMed Central identifier	PMC7365115
has PubMed identifier	32702641
schema:publication	Mult Scler Relat Disord
resource representing a document's body	covid:6f953f0b9f727b9ffb51103bbd8b41a7882b7061#body_text
is schema:about of	named entity 'questionnaires' named entity 'Group' named entity 'questionnaires' named entity 'provide' named entity 'individuals' named entity 'COVID-19' named entity 'anxiety' named entity 'Results' named entity 'experience' named entity 'Hamilton' named entity 'psychosocial support' named entity 'patients' named entity 'Patients' named entity 'coronavirus' named entity 'infection' named entity 'COVID-19' named entity 'April 2020' named entity 'depression' named entity 'COVID-19 pandemic' named entity 'treatment options' named entity 'relapsing-remitting multiple sclerosis' named entity 'RRMS' named entity 'RRMS' named entity 'HAM-A' named entity 'Psychological status' named entity 'psychological distress' named entity 'Ruet' named entity 'COVID-19 pandemic' named entity 'co-morbidities' named entity 'HAMD' named entity 'disability status' named entity 'interferons' named entity 'Ozamiz' named entity 'QoL' named entity 'probability' named entity 'general population' named entity 'Public health' named entity 'RRMS' named entity 'RRMS' named entity 'RRMS' named entity 'respiratory tract infections' named entity 'COVID-19 outbreak' named entity 'anxiety' named entity 'RRMS' named entity 'COVID' named entity 'RRMS' named entity 'RRMS' named entity 'RRMS' named entity 'RRMS' named entity 'QoL' named entity 'interquartile range' named entity 'global health emergency' named entity 'methylprednisolone' named entity 'infection' named entity 'standard deviation' named entity 'emotional distress' named entity 'RRMS' named entity 'inflammatory' named entity 'immunosuppressive' named entity 'higher risk' named entity 'emotional response' named entity 'infection' named entity 'RRMS' named entity 'RRMS' named entity 'treatment options' named entity 'global population' named entity 'Multiple Sclerosis' named entity 'global health' named entity 'RRMS' named entity 'interferons' named entity 'anxiety' named entity 'telemedicine' named entity 'HAM-A' named entity 'epidemiological' named entity 'HAM-D'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software